Cancer BiologybioRxivPreprint
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies
Stephen E. Kurtz, Christopher A. Eide, Andy J. Kaempf…·Jeffrey W Tyner
This paper develops a rapid qPCR-based gene expression profiler to predict AML patient response to standard therapies using cell state and BCL2 family gene expression signatures.
DOI 10.1101/2025.10.08.681215